Psychemedics Corporation Announces 2013 Record First Quarter Revenues

DECLARES 67th CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass., May 7, 2013 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2013. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of May 17, 2013 to be paid on May … Read more

Psychemedics & TruTouch Announce US Sales/Marketing Distribution Agreement

ACTON and FRAMINGHAM, Mass., Feb. 28, 2013,/PRNewswire/ — Psychemedics Corporation, (NASDAQ: PMD) and TruTouch Technologies, Inc. today announced that they have signed an agreement to market TruTouch’s rapid optical alcohol detection and biometric test in the US. The workplace sobriety assurance solution utilizes an optical-based, non-invasive near-infrared sensor that quickly and accurately measures alcohol consumption. … Read more

Psychemedics Awarded ISO/IEC 17025 International Accreditation

Worldwide Leader in Hair Testing For Drugs of Abuse Recognized Internationally For Highest Quality Laboratory Standards ACTON, Mass., Nov. 7, 2011 /PRNewswire/ — Psychemedics Corporation, hair testing for drugs of abuse pioneer and leader for 25 years, announced today that its laboratory has received international accreditation (ISO/IEC 17025:2005) for a broad spectrum of laboratory testing … Read more